Original language | English |
---|---|
Publication status | Published - 20 Jun 2012 |
A randomized multicenter trial of epirubicin, oxaliplatin, and capecitabine (EOC) plus panitumumab in advanced esophagogastric cancer (REAL3)
T.S. Waddell, I. Chau, Y. Barbachano, D.G. de Castro, A. Wotherspoon, C. Saffery, G.W. Middleton, J. Wadsley, D.R. Ferry, W. Mansoor, T.D.L. Crosby, F.Y. Coxon, D. Smith, J.S. Waters, T. Iveson, S. Falk, S. Slater, A.F.C. Okines, D. Cunningham
Research output: Contribution to conference › Other › peer-review